A set of First Trimester Screenings are done between 10 to 13 +6days weeks of pregnancy to screen the growing fetus for underlying suspect chromosomal abnormalities. This screening requires maternal serum or blood samples for a test that includes a combination of biochemical and biophysical markers.
This screening combines biochemical (Dual Marker Test) and biophysical (Nuchal transparency & Nasal Bone scan) markers to provide high detection rate of chromosomal abnormalities. The analysed markers are:
Free hCGβ ((Free Beta human chorionic gonadotropin)
PAPP-A (Pregnancy-associated Plasma Protein A))
NT (Nuchal translucency)
NB (Nasal bone scan)
FHR (Fetal Heart Rate)
Measures the levels pregnancy-related placental protein A, UAPI, MAF, and PLGF in a pregnant woman’s blood to help predict early-onset of pre-eclampsia
Biochemical marker: AFP + Ultrasound
It combines biochemical screening with additional markers for effective diagnosis of chromosomal defects. Its enhanced precision reduces the need for more intrusive methods.
It allows estimating the risk of chromosomal conditions such as Down Syndrome, Edward’s Syndrome, early onset of PE and ONTD
Provides results in just 48 hours
Reduces the need for mother’s to go through high-risk invasive testing
Provides Free Post-Test Genetic Counselling to understand the results better.
Testing and analysis of the sample are conducted in the lab.
The results are shared within 48 hours
Post-result free genetic counselling is offered to parents to understand the test results better.